These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22379688)

  • 1. Establishment, maintenance, and availability of records: amendment to record availability requirements. Interim final rule; request for comments.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(36):10658-62. PubMed ID: 22379688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment, maintenance, and availability of records: amendment to record availability requirements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 Apr; 79(65):18799-802. PubMed ID: 24716304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and maintenance of records under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(236):71561-655. PubMed ID: 15586951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further amendments to general regulations of the Food and Drug Administration to incorporate tobacco products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(22):5171-6. PubMed ID: 22359802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant formula record and record retention requirements--FDA. Final rule.
    Fed Regist; 1991 Dec; 56(247):66566-73. PubMed ID: 10116071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May; 64(93):26282-7. PubMed ID: 10558530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amendment to examination and investigation sample requirements--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(186):51297-9. PubMed ID: 10185810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical devices; humanitarian use of devices--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registration of food facilities under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(190):57505-9. PubMed ID: 16200686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.